| Today's News and Trends | In her remarks at the American Hospital Association’s annual meeting, CMS Administrator Seema Verma, MPH, offered some criticism of current accountable care organizations (ACOs) that haven’t taken on downside risk, hinting those payment models may be targeted by CMS regulations. In her remarks at the American Hospital Association’s annual meeting, CMS Administrator Seema Verma, MPH, offered some criticism of current accountable care organizations (ACOs) that haven’t taken on downside risk, hinting those payment models may be targeted by CMS regulations. | | |
| The potential of genetic testing for chronic disease is substantial—and these possible positives are understood by many primary care providers (PCPs). Still, many feel unprepared to deal with patients at high risk for such conditions, while others questioned their ability to interpret genetic testing results. The potential of genetic testing for chronic disease is substantial—and these possible positives are understood by many primary care providers (PCPs). Still, many feel unprepared to deal with patients at high risk for such conditions, while others questioned their ability to interpret genetic testing results. | | |
| “For the first time, CMS is organizing and focusing our efforts to apply a rural lens to the vision and work of the agency,” CMS Administrator Seema Verma, MPH, said in a statement. “For the first time, CMS is organizing and focusing our efforts to apply a rural lens to the vision and work of the agency,” CMS Administrator Seema Verma, MPH, said in a statement. | | |
| President Donald Trump is looking to a rarely-utilized process called “rescission” to cut $15 billion in federal spending he already signed into law earlier this year—with much of the reductions coming from programs like the Centers for Medicare and Medicaid Innovation (CMMI) and the Children’s Health Insurance Program (CHIP). President Donald Trump is looking to a rarely-utilized process called “rescission” to cut $15 billion in federal spending he already signed into law earlier this year—with much of the reductions coming from programs like the Centers for Medicare and Medicaid Innovation (CMMI) and the Children’s Health Insurance Program (CHIP). | | |
| Kansas’s proposal to impose a three-year lifetime limit on Medicaid benefits has been formally rejected by CMS, with Administrator Seema Verma, MPH, saying the agency has to ensure the program “remains a safety net for those that need it most.” Kansas’s proposal to impose a three-year lifetime limit on Medicaid benefits has been formally rejected by CMS, with Administrator Seema Verma, MPH, saying the agency has to ensure the program “remains a safety net for those that need it most.” | | |
| Nashville, Tennessee’s Change Healthcare has announced a collaboration with tech giants Microsoft and Adobe on a new patient engagement solution—one that Change promised would unite “engagement orchestration proven to work in consumer marketing with industry leading healthcare IT across the continuum of care.” Nashville, Tennessee’s Change Healthcare has announced a collaboration with tech giants Microsoft and Adobe on a new patient engagement solution—one that Change promised would unite “engagement orchestration proven to work in consumer marketing with industry leading healthcare IT across the continuum of care.” | | |
| New Hampshire will become the fourth state to impose work requirements on Medicaid beneficiaries, according to a May 7 joint statement from CMS, HHS and New Hampshire Governor Chris Sununu. New Hampshire will become the fourth state to impose work requirements on Medicaid beneficiaries, according to a May 7 joint statement from CMS, HHS and New Hampshire Governor Chris Sununu. | | |
| According to CNBC, Elliott Management made an all-cash deal for Athenahealth on Monday morning. Elliott’s bid is for $160 a share—a 27 percent premium to the Massachusetts-based healthcare technology company’s Friday afternoon price. According to CNBC, Elliott Management made an all-cash deal for Athenahealth on Monday morning. Elliott’s bid is for $160 a share—a 27 percent premium to the Massachusetts-based healthcare technology company’s Friday afternoon price. | | |
| May 9 marks 100 days since Alex Azar was sworn in as the second HHS Secretary under President Donald Trump. Judging by what lobbyists, policy experts and Democrats said to Axios, he’s seen in a more positive light than his predecessor Tom Price, MD. May 9 marks 100 days since Alex Azar was sworn in as the second HHS Secretary under President Donald Trump. Judging by what lobbyists, policy experts and Democrats said to Axios, he’s seen in a more positive light than his predecessor Tom Price, MD. | | |
| |
|
| ![]() | |
|
